CZO.V : Summary for Ceapro Inc - Yahoo Finance

Canadian Markets open in 4 hrs 31 mins

Ceapro Inc. (CZO.V)


TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
1.300.00 (0.00%)
At close: 3:59PM EDT
People also watch
CRH.TOBUS.VPHM.VNYX.VRX.V
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.30
Open1.34
Bid1.28 x
Ask1.32 x
Day's Range1.29 - 1.35
52 Week Range0.70 - 2.47
Volume90,365
Avg. Volume158,779
Market Cap97.89M
Beta4.69
PE Ratio (TTM)25.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks Small Cap Research15 days ago

    CZO.V: Focus Shifts to Development Programs

    On April 6, 2017, Ceapro Inc. (CZO.V) released full-year 2016 financial and operational results.  2016 revenues of $13.7 million rose 28% over the prior year and earnings of 5.1c posted a near 50% increase on an adjusted basis.   These results are below our estimates of $14.7 million in revenues and earnings of 6.2c (note that all currency herein is denominated in Canadian dollars). By geography, on a year over year basis, 2016 sales increases in the US, Canada, Germany and Other were offset by declines in China.  In the fourth quarter, sales fell 29% vs. Q4:15 as Germany and China did not maintain previous year sales’ levels.  The 4Q:16 vs. 4Q:15 difference was also attributable to a significant reduction in orders for beta glucan.   Sequentially, Ceapro experienced quarterly declines in US, Germany, and Canada but increases in China and Other regions.

  • Marketwired21 days ago

    Ceapro Inc. Reports 2016 Financial Results and Provides Corporate Update

    Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced its financial results for ...

  • Accesswire21 days ago

    Research Reports Initiated on Healthcare Stocks Medifocus, Ceapro, and Crescita Therapeutics

    LONDON, UK / ACCESSWIRE / April 6, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...